Banque Cantonale Vaudoise Obs Eva Sa Transaction History

Banque Cantonale Vaudoise

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.14 - $0.21 $1,101 - $1,652	-7,868 Reduced 23.94%	25,000 $3,000
Q3 2022 Oct 17, 2022	BUY	$0.14 - $1.83 $560 - $7,320	4,000 Added 13.86%	32,868 $4,000
Q1 2022 May 09, 2022	BUY	$1.1 - $2.17 $18,700 - $36,890	17,000 Added 143.24%	28,868 $44,000
Q2 2021 Aug 11, 2021	SELL	$2.56 - $3.35 $56,657 - $74,142	-22,132 Reduced 65.09%	11,868 $37,000
Q1 2021 May 11, 2021	BUY	$2.01 - $5.05 $68,340 - $171,700	34,000 New	34,000 $110,000

Q4 2020 Feb 05, 2021	SELL	$1.89 - $2.55 $15,120 - $20,400	-8,000 Closed	0 $0
Q3 2020 Oct 30, 2020	BUY	$2.46 - $6.15 $19,087 - $47,717	7,759 Added 3219.5%	8,000 $19,000
Q4 2019 Feb 10, 2020	BUY	$2.48 - $8.1 $597 - $1,952	241 New	241 $1,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.